News

A new cheaper biosimilar version of Sanofi's Lantus (insulin ... Abasaglar is priced at £35.28 for both its 100unit/ml 3ml x 5 cartridges and a 100unit/ml 3ml 'KwikPen', while Lantus costs £41. ...
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...
CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
The once-weekly insulin analog lowered A1c as effectively as once-daily formulations in three new trials in type 2 diabetes.
Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...
Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins Human insulin presents Indian companies an opportunity estimated at Rs ...
In this study, we examined the pharmacokinetic and pharmacodynamic dose-response effects of single subcutaneous injections of insulin glargine in obese type 2 diabetic individuals. Our study ...
Civica will make generic versions of the three most popular brands of insulin — Lantus, Humalog and Novolog, which account for more than 80% of the U.S. market.
Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved ...
India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...